English
Home > Products > CAS NO 518048-05-0

China CAS NO 518048-05-0 Factory

Our goal is usually to consolidate and improve the high quality and service of existing solutions, meanwhile continuously create new items to meet unique customers' requires for CAS NO 518048-05-0,518048-05-0,Raltegravir API, If you're interested in any of our merchandise or wish to talk about a tailored buy, you should really feel totally free to get hold of us.
CAS NO 518048-05-0, Our company promises: reasonable prices, short production time and satisfactory after-sales service, we also welcome you to visit our factory at any time you want. Wish we've got a pleasant and long terms business together!!!

Related Products

Hot Products

  • Ethyl 4,6-dichloropyrridazine-3-carboxylate

    Ethyl 4,6-dichloropyrridazine-3-carboxylate

    Product Name:Ethyl 4,6-dichloropyrridazine-3-carboxylate
    Molecular Formula:C7H6Cl2N2O2
    Molecular Weight:221.04
    CAS Registry Number:679406-03-2
  • ANSAMITOCIN P-3

    ANSAMITOCIN P-3

    Product Name:ANSAMITOCIN P-3
    Molecular Formula:C32H43ClN2O9
    Molecular Weight:635.14
    CAS Registry Number:66547-09-9/66584-72-3
  • Ilepcimide

    Ilepcimide

    Product Name:Ilepcimide
    Molecular Weight:259.30
    CAS Registry Number:82857-82-7
  • Ascorbic Acid

    Ascorbic Acid

    Product Name:Ascorbic Acid
    Molecular Formula:C6H8O6
    Molecular Weight:176.12
    CAS Registry Number:50-81-7
  • Tenofovir alafenamide hemifumarate

    Tenofovir alafenamide hemifumarate

    Product Name:Tenofovir alafenamide hemifumarate
    Molecular Formula:C25H33N6O9P
    Molecular Weight;592.55
    CAS Registry Number;1392275-56-7
  • Pazopanib Hydrochloride

    Pazopanib Hydrochloride

    Product Name:Pazopanib Hydrochloride
    Molecular Formula:C21H24ClN7O2S
    Molecular Weight;473.98
    CAS Registry Number;635702-64-6
  • Related Blog
  • Reviews

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept